HB 1755-FN (2026): relative to the 340B discounted drug purchasing program.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “HB 1755-FN (2026): relative to the 340B discounted drug purchasing program.” Granite Record, https://graniterecord.org/bill/2026/hb1755. Accessed 19 Oct. 2026.
- APA
- Granite Record. (n.d.). HB 1755-FN (2026): relative to the 340B discounted drug purchasing program. Retrieved 19 Oct. 2026, from https://graniterecord.org/bill/2026/hb1755
- Chicago
- Granite Record. “HB 1755-FN (2026): relative to the 340B discounted drug purchasing program.” Accessed 19 Oct. 2026. https://graniterecord.org/bill/2026/hb1755.
- BibTeX
@misc{bill-2026-hb1755, title = {HB 1755-FN (2026): relative to the 340B discounted drug purchasing program.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2026/hb1755}, note = {Accessed 19 Oct. 2026} }
HB 1755-FN (2026)
relative to the 340B discounted drug purchasing program.
- Status: Referred for interim study
- Term: 2025-2026
- House committee: Health, Human Services and Elderly Affairs
- Subject: Welfare/Medicare/Medicaid
The Story
It was introduced on January 7, 2026 and referred to the House Health, Human Services and Elderly Affairs committee. The committee held a public hearing on January 21, 2026, with 22 people signed in online: 6 in support and 16 in opposition. The committee met in executive session on January 28, 2026 to vote on its recommendation. The committee voted unanimously, 18–0, to recommend that the House study it after the session ends, and the report was placed on the consent calendar. On February 12, 2026 the House voted to study it after the session ends on a voice vote. The committee held work sessions on September 23, 2026 and September 29, 2026. The committee met in executive session on October 15, 2026 to vote on its recommendation.
Sponsors
- Rep. Yury Polozov (R - Merr 10) (prime sponsor)
- Rep. Melissa Litchfield (R - Rock 32)
- Rep. Jordan Ulery (R - Hills 13)
Hearings and Sessions
- January 21, 2026, 11:30 AM: public hearing, House Health, Human Services and Elderly Affairs, GP 158
- January 28, 2026, 2:30 PM: executive session, House Health, Human Services and Elderly Affairs, GP 158
- February 12, 2026: consent calendar, House
- September 23, 2026, 9:30 AM: subcommittee work session, House Health, Human Services and Elderly Affairs, GP 230
- September 29, 2026, 9:30 AM: subcommittee work session, House Health, Human Services and Elderly Affairs, GP 230
- October 15, 2026, 10:00 AM: executive session, House Health, Human Services and Elderly Affairs, GP 230
Votes
- February 12, 2026, House: Refer for Interim Study — voice vote, passed
The Docket
- January 7, 2026: Introduced 01/07/2026 and referred to Health, Human Services and Elderly Affairs
- January 21, 2026: Public Hearing: 01/21/2026 11:30 am GP 158
- January 28, 2026: Executive Session: 01/28/2026 02:30 pm GP 158
- January 28, 2026: Committee Report: Refer for Interim Study 01/28/2026 (Vote 18-0; CC)
- February 12, 2026: Refer for Interim Study: MA VV 02/12/2026
- September 23, 2026: Subcommittee Work Session: 09/23/2026 09:30 am GP 230
- September 29, 2026: Subcommittee Work Session: 09/29/2026 09:30 am GP 230
- October 15, 2026: Executive Session: 10/15/2026 10:00 am GP 230